News | TCTAP 2023

PREVENT Trial

Future Perspective on Ongoing Trials from AMC

News | TCTAP 2023

OCTIVUS Trial

Future Perspective on Ongoing Trials from AMC

News | TCTAP 2023

30 Years History of FFR: From the Concept to Current Status - Legend's Perspective

Opening of TCTAP 2023 & Key Note Lectures

News | TCTAP 2023

Upfront 2-Stent; New Concept in LM Bifurcation PCI

All Bifurcation PCI

News | TCTAP 2023

How Can We Improve Reperfussion Therapy in AMI

Acute Coronary Syndrome

News | TCTAP 2023

Left Main Revascularization; Consensus and Gaps in 2023

LM & Multi-Vessel Diseases and Bifurcation & CTO After ISCHEMIA Study

News | SummitMD

Extended BEST trial offers insight into murky dispute over optimal long-term revasc strategy in MVCAD

10-year follow-up of BEST study from 2015 latest to show near ¡®clinical equipoise¡¯ between contemporary PCI versus CABG for multivessel disease